Physician profile
Paige C Proctor
NPI 1487214235
$1,688.93
in general payments reported to CMS, 2019-2025
17 companies · $67.09 in 2025
The $67.09 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $893 · 2022: $107 · 2023: $274 · 2024: $347 · 2025: $67.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $554.88 | 2021-2025 | Wegovy |
| Lilly USA, LLC | $199.27 | 2021-2025 | Zepbound |
| Abbvie INC. | $143.95 | 2021-2024 | |
| Medtronic, INC. | $132.50 | 2021 | |
| Dexcom, INC. | $119.42 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $114.54 | 2021 | |
| Insulet Corporation | $100.58 | 2021 | |
| Xeris Pharmaceuticals, INC. | $77.87 | 2021 | |
| Zealand Pharma US, INC. | $51.41 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $39.89 | 2022-2024 | Contrave |
| Amarin Pharma, INC. | $38.02 | 2021 | |
| Merck Sharp & Dohme LLC | $33.32 | 2021 | |
| Radius Health, INC. | $20.50 | 2021 | |
| Mannkind Corporation | $16.32 | 2021 | |
| Abbott Laboratories | $15.96 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.69 | 2021 | |
| Clarus Therapeutics INC. | $14.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paige Proctor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.